{"transactions":[{"id":3861272,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":164760,"kind":"person","name":"Seidel Ronald D. III","position":1,"cik":"0001724872","reported_name":"Seidel Ronald D. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-25T20:49:37.000Z","date":"2018-07-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight semi-annual installments beginning July 23, 2018."}],"balance_after":75000,"derivative":{"exercise_price":11.54,"expiration_date":"2025-07-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-043906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118043906/doc4.xml","form_type":"4"}}]}